Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bids 1M 0.0175
$BIEI in discussions with a number of potential partners for their #cancer research. !!!
BIEI NEWS MJ play +45% up
NEWS Mar 2, 2017 Premier Biomedical Retires Convertible Debt
http://www.marketwired.com/press-release/premier-biomedical-retires-convertible-debt-otcqb-biei-2200100.htm
and
"The company reports they have been in discussion with a number of potential partners with whom their promising patent-pending antibody drug for breast cancer can be developed."
$BIEI
BIEI +45% up MJ play
NEWS Mar 2, 2017 Premier Biomedical Retires Convertible Debt
http://www.marketwired.com/press-release/premier-biomedical-retires-convertible-debt-otcqb-biei-2200100.htm
and
"The company reports they have been in discussion with a number of potential partners with whom their promising patent-pending antibody drug for breast cancer can be developed."
$BIEI
The company reports they have been in discussion with a number of potential partners with whom their promising patent-pending antibody drug for breast cancer can be developed.
http://www.marketwired.com/press-release/premier-biomedical-retires-convertible-debt-otcqb-biei-2200100.htm
$BIEI
The company reports they have been in discussion with a number of potential partners with whom their promising patent-pending antibody drug for breast cancer can be developed.
http://www.marketwired.com/press-release/premier-biomedical-retires-convertible-debt-otcqb-biei-2200100.htm
$BIEI
BIEI NEWS
+27% up
NEWS Mar 2, 2017 Premier Biomedical Retires Convertible Debt
http://www.marketwired.com/press-release/premier-biomedical-retires-convertible-debt-otcqb-biei-2200100.htm
and
"The company reports they have been in discussion with a number of potential partners with whom their promising patent-pending antibody drug for breast cancer can be developed."
$BIEI
BIEI +27% up
NEWS Mar 2, 2017 Premier Biomedical Retires Convertible Debt
http://www.marketwired.com/press-release/premier-biomedical-retires-convertible-debt-otcqb-biei-2200100.htm
and
"The company reports they have been in discussion with a number of potential partners with whom their promising patent-pending antibody drug for breast cancer can be developed."
$BIEI
GIGL Is a good example
Feb 15 - close 0.022
Feb 16 - Giggles N’ Hugs Announces full Debt Conversion with Iconic
Feb 27 - 0.181 - 7th day after the announcement up +722%
80% buy vol.
The last flippers...
GIGL Is a good example
Feb 15 - close 0.022
Feb 16 - Giggles N’ Hugs Announces full Debt Conversion with Iconic
Feb 27 - 0.181 - 7th day after the announcement up +722%
BIEI - NEWS
+40% up
NEWS Mar 2, 2017 Premier Biomedical Retires Convertible Debt
http://www.marketwired.com/press-release/premier-biomedical-retires-convertible-debt-otcqb-biei-2200100.htm
and
The company reports they have been in discussion with a number of potential partners with whom their promising patent-pending antibody drug for breast cancer can be developed.
$BIEI
BIEI +40% up
NEWS Mar 2, 2017 Premier Biomedical Retires Convertible Debt
http://www.marketwired.com/press-release/premier-biomedical-retires-convertible-debt-otcqb-biei-2200100.htm
and
The company reports they have been in discussion with a number of potential partners with whom their promising patent-pending antibody drug for breast cancer can be developed.
$BIEI
This is just the beginning ...
The company reports they have been in discussion with a number of potential partners with whom their promising patent-pending antibody drug for breast cancer can be developed.
Premier Biomedical Retires Convertible Debt https://t.co/doMBcUTN6T
— Premier Biomedical (@PremierBiomedic) March 2, 2017
NEWS - Premier Biomedical Retires Convertible Debt
http://www.premierbiomedical.com/premier-biomedical-retires-convertible-debt/
+19 % !!!!
Revenues from $BIEI ‘s pain relief products could potentially fund the company’s anti-cancer antigen.
https://twitter.com/upticknewswire/status/837268785706987521
Premier Biomedical Inc (OTCMKTS:BIEI) Has A Decent Catalyst Inflow Ahead
Wednesday, 01 Mar 2017
https://www.insiderfinancial.com/heres-our-take-on-premier-biomedical-inc-otcmktsbieis-strategy/119870/
$BIEI
Strong NEWS !!!
I believe in official sources.
Outstanding Shares 447,249,183 a/o Feb 27, 2017
Float 43,475,970 a/o Feb 27, 2017
404M - 90% shares
43M - 10%
Some investor may have bought 90% of the company ... who knows?
Only today has been updated, we will see the reaction tomorrow and the next few days.
I believe in official information. 43M
I believe in official information. 43M
Official source!
use Mozilla Firefox browser
Any investor holds 403M of shares ?! It can only be something similar to this.
90% are restricted. It's amazing.
Official source! If it's true, will be amazing.
http://www.otcmarkets.com/stock/BIEI/profile
Float 43,475,970 a/o Feb 27, 2017 - Updated this afternoon !
Outstanding Shares 447,249,183 a/o Feb 27, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 43,475,970 a/o Feb 27, 2017 ????
http://www.otcmarkets.com/stock/BIEI/profile
End of dilution
and the float 43M ...
not forget: news this week
"little trembling baby hands" ahah
0.014 / 0.015
$BIEI
MJ stock
!!!! CEO William Hartman Interviewed on Uptick Newswire’s “Stock Day” Radio Show. !!!!! Big news, listen carefully
http://www.premierbiomedical.com/ceo-william-hartman-interviewed-uptick-newswires-stock-day-radio-show/
$BIEI MJ stock
!!!! CEO William Hartman Interviewed on Uptick Newswire’s “Stock Day” Radio Show. !!!!! Big news, listen carefully
http://www.premierbiomedical.com/ceo-william-hartman-interviewed-uptick-newswires-stock-day-radio-show/
!!!! CEO William Hartman Interviewed on Uptick Newswire’s “Stock Day” Radio Show. !!!!! Big news, listen carefully
http://www.premierbiomedical.com/ceo-william-hartman-interviewed-uptick-newswires-stock-day-radio-show/